Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs). Issue 1 (16th February 2017) - Cabibbo, G.; Cacciola, I.; Cannavò, M.R.; Madonia, S.; Calvaruso, V.; Petta, S.; Distefano, M.; Larocca, L.; Prestileo, T.; Tinè, F.; Digiacomo, A.; Bertino, G.; et al.